SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014)
SELLAS Life Sciences' (SLS) quarterly Capital Leases came in at $17000.0 in Q3 2014, down 43.33% year-on-year from $30000.0 in Q3 2013, and down 10.53% on a QoQ basis from $19000.0 in Q2 2014.
SELLAS Life Sciences (SLS) Capital Leases (2010 - 2014) Analysis & Trends
SELLAS Life Sciences (SLS) has 5 years of Capital Leases data on file, last reported at $17000.0 in Q3 2014.
- On a quarterly basis, Capital Leases fell 43.33% year-over-year to $17000.0 in Q3 2014; TTM through Sep 2014 was $17000.0, a 43.33% decrease from a year earlier, with the FY2013 full-year figure at $26000.0, down 49.02% from the prior year.
- Capital Leases for Q3 2014 stood at $17000.0, down from $19000.0 in the prior quarter.
- Over the last five years, Capital Leases for SLS reached as high as $51000.0 in Q3 2012 and fell as low as $10000.0 in Q2 2011.
- Historically, Capital Leases has averaged $29571.4 across 5 years, with a median of $28000.0 in 2013.
- Across the five-year window, Capital Leases soared 264.29% in 2012 and sank 54.9% in 2014, its largest moves.
- Year by year, Capital Leases stood at $20000.0 in 2010, then surged by 60.0% to $32000.0 in 2011, then soared by 59.38% to $51000.0 in 2012, then slumped by 49.02% to $26000.0 in 2013, then tumbled by 34.62% to $17000.0 in 2014.
- Per Business Quant data, the three most recent Capital Leases figures were $17000.0 in Q3 2014, $19000.0 in Q2 2014, and $23000.0 in Q1 2014.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - |
| 10 | SELLAS Life Sciences | 3.23 Mn | 3.23 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2014 | 17,000.00 |
| Jun 30, 2014 | 19,000.00 |
| Mar 31, 2014 | 23,000.00 |
| Dec 31, 2013 | 26,000.00 |
| Sep 30, 2013 | 30,000.00 |
| Jun 30, 2013 | 34,000.00 |
| Mar 31, 2013 | 51,000.00 |
| Dec 31, 2012 | 51,000.00 |
| Sep 30, 2012 | 51,000.00 |
| Mar 31, 2012 | 36,000.00 |
| Dec 31, 2011 | 32,000.00 |
| Sep 30, 2011 | 14,000.00 |
| Jun 30, 2011 | 10,000.00 |
| Dec 31, 2010 | 20,000.00 |